Hypothyroidism — insufficient thyroid hormone production by the thyroid gland — is more common among veterans than the general population, particularly for veterans with Agent Orange exposure history. The condition affects metabolism, energy levels, cardiovascular function, mood, cognition, and weight regulation. Left untreated or undertreated, it can cause severe disability. Managed with thyroid hormone replacement (levothyroxine), it is often controlled — but controlled does not mean non-ratable under VA law.
VA rates hypothyroidism under Diagnostic Code 7903 at 38 CFR 4.119. The rating can range from 10% (medication-controlled, no other symptoms) to 100% (severe manifestations including cardiovascular involvement and mental disturbance). In January 2022, hypothyroidism was added to the Agent Orange presumptive list — a landmark change that makes thousands of Vietnam-era veterans eligible for service connection without needing to establish an in-service nexus. This guide covers the full regulatory framework, evidence strategy, Agent Orange presumptive qualification, and secondary condition opportunities.
VA rates hypothyroidism under Diagnostic Code 7903, "Hypothyroidism," at 38 CFR 4.119. The rating schedule for DC 7903 assigns ratings based on clinical manifestations and functional impairment — not on lab values alone. A stable TSH on medication does not preclude a rating; what matters is the clinical picture and functional residuals.
| Rating | Regulatory Criteria | Key Clinical Features | Notes |
|---|---|---|---|
| 10% | Requires continuous medication, with no other functional impairment | Stable on levothyroxine, no significant symptoms, routine TSH monitoring only | Most common rating for controlled hypothyroidism; still ratable because continuous medication is required |
| 30% | Fatigability; or; constipation; or; mental sluggishness | Persistent fatigue despite medication, cognitive "brain fog," chronic constipation, depression, cold intolerance | Any one of these symptoms qualifies; fatigue and cognitive issues are most commonly documented |
| 60% | Muscular weakness; or; mental disturbance (e.g., dementia, slurred speech, etc.); or; weight gain; or; acne; or; loss of hair; or; anorexia; or; other findings | Significant weight gain, hair loss (alopecia), muscle weakness, cognitive/mood disturbance, cold-induced symptoms | "Other findings" is broad — additional symptoms documented by treating physician may support 60% |
| 100% | Cold intolerance; or; muscular weakness; or; cardiovascular involvement; or; mental disturbance (severe) | Pericardial effusion, bradycardia, severe cognitive impairment, myxedema, life-threatening cardiac manifestations | Cardiovascular or severe mental disturbance features required; rarely awarded without hospitalization or cardiac testing |
The vast majority of veterans with hypothyroidism receive a 10% rating — which reflects medication-controlled hypothyroidism with no additional documented symptoms. This is often appropriate for veterans whose condition is genuinely well-controlled with no residuals. However, many veterans with true 30% symptoms — persistent fatigue, cognitive difficulties, weight gain, depression — are incorrectly rated at 10% because these symptoms are not adequately documented at VA compensation exams or in medical records.
The key to a 30% or 60% rating is thorough symptom documentation. If you experience persistent fatigue despite adequate levothyroxine therapy, report it at every medical appointment and ensure it appears in your records. If you have depression related to hypothyroidism, get it documented. If you have unexplained weight gain, hair loss, or cognitive symptoms, have your treating physician document these as hypothyroid residuals. The rating is determined by what's in the record — not by what you tell the VA rater verbally.
The 10% rating for hypothyroidism — "requires continuous medication, with no other functional impairment" — establishes a critical principle: the need for permanent thyroid hormone replacement therapy alone qualifies for a 10% rating. Veterans sometimes believe they must be "bad enough" to get any rating; but if your thyroid gland has stopped producing adequate hormone and you require daily levothyroxine indefinitely, that alone satisfies the 10% criteria. This is significant for Agent Orange veterans who may not have significant symptoms but still require lifelong medication.
All VA disability compensation is federally income tax-free under 38 U.S.C. § 5301. The following 2026 monthly rates apply to hypothyroidism rated under DC 7903:
| Rating | Veteran Only | + Spouse | + Spouse + 1 Child | Annual (Veteran Only) |
|---|---|---|---|---|
| 10% | $175.51 | $175.51 | $175.51 | $2,106.12 |
| 30% | $537.42 | $601.58 | $650.40 | $6,448.44 |
| 60% | $1,395.93 | $1,520.27 | $1,620.01 | $16,751.16 |
| 100% | $3,737.85 | $4,063.63 | $4,244.05 | $44,854.20 |
On January 13, 2022, the VA published a final rule adding hypothyroidism to the list of Agent Orange presumptive conditions under 38 CFR 3.309(e). This rule implemented findings from the National Academy of Sciences (NAS) review under the Agent Orange Act (codified at 38 U.S.C. § 1116), which found sufficient scientific evidence of an association between dioxin exposure (the herbicide 2,4,5-T component of Agent Orange) and thyroid dysfunction, including hypothyroidism.
Before January 2022, Vietnam veterans with hypothyroidism had to establish direct service connection through a nexus letter — a significant burden given that hypothyroidism typically develops years or decades after exposure. The 2022 presumptive rule eliminates that burden entirely: qualifying veterans with hypothyroidism need only demonstrate the current diagnosis and qualifying service location. No nexus letter. No in-service documentation of thyroid problems. No evidence that exposure caused the condition.
Under 38 CFR 3.307, a presumptive service connection means that if a veteran served in a qualifying location and has a listed condition, VA must presume that the condition was caused by the in-service exposure — without requiring the veteran to prove causation. The veteran still bears the burden of establishing: (1) qualifying service (time and location); and (2) current diagnosis of the listed condition. Once both are established, service connection is granted automatically under the presumption.
The Agent Orange presumptive list at 38 CFR 3.309(e) now includes: ischemic heart disease, type 2 diabetes, Parkinson's disease, hypertension (added 2022), B-cell leukemias (CLL, hairy cell), non-Hodgkin's lymphoma, Hodgkin's disease, multiple myeloma, prostate cancer, respiratory cancers, soft-tissue sarcomas, bladder cancer, AL amyloidosis, peripheral neuropathy (early-onset), and hypothyroidism (added 2022). See the comprehensive Agent Orange presumptive conditions guide.
The Agent Orange hypothyroidism presumptive applies to veterans who served in any of the following locations and time periods:
| Service Category | Location | Time Period | Citation |
|---|---|---|---|
| Vietnam In-Country | Republic of Vietnam or its territorial waters | January 9, 1962 – May 7, 1975 | 38 CFR 3.307(a)(6)(iii) |
| Blue Water Navy | Territorial sea of the Republic of Vietnam (within 12 nautical miles) | January 9, 1962 – May 7, 1975 | 38 CFR 3.307(a)(6)(iv); P.L. 116-23 |
| Thailand — Thai Air Force Bases | U.S. or Royal Thai Air Force bases | January 9, 1962 – May 7, 1975 | 38 CFR 3.307(a)(6)(iv) |
| Korea — DMZ | Korean Demilitarized Zone | September 1, 1967 – August 31, 1971 | 38 CFR 3.307(a)(6)(iv) |
| C-123 Aircraft | Air Force Reserve units that flew contaminated C-123 aircraft | Post-Vietnam, specific units | 38 CFR 3.307(a)(6)(v) |
| Johnston Atoll | Johnston Atoll during herbicide storage/testing | January 1, 1972 – September 30, 1977 | 38 CFR 3.307(a)(6)(iv) |
The Blue Water Navy Vietnam Veterans Act of 2019 (Public Law 116-23) extended Agent Orange presumptives to Navy and Coast Guard veterans who served in the territorial sea — within 12 nautical miles of the coast — during the qualifying period. Veterans who served aboard ships that operated in this zone are presumed exposed. The VA maintains a ships list at va.gov; if your vessel is listed, no further proof of territorial sea operation is needed. Blue Water Navy veterans whose ships are NOT on the VA list may still qualify if they can demonstrate their ship operated within 12 nautical miles through deck logs, ship histories, or other documentation.
Thailand veterans who served at U.S. or Royal Thai Air Force bases qualify for the presumptive if they served in perimeter or security duty (where herbicide exposure was most likely around base perimeters) or in other roles where direct contact with herbicide-sprayed vegetation was probable. Documentation from unit records, buddy statements, or Air Force base histories helps establish qualifying service if the veteran's specific duty location is not automatically documented. See VA benefits for Vietnam veterans guide.
For veterans who don't qualify for Agent Orange presumptive service connection (e.g., Gulf War, post-9/11, or non-Vietnam-era veterans), hypothyroidism can still be directly service-connected through the standard three-element pathway: current diagnosis + in-service event or incurrence + medical nexus.
Hypothyroidism during service is documented in military medical records — TSH elevation, thyroid medication prescribed, or referral to endocrinology during service establishes in-service incurrence. Even if thyroid values were borderline during service and overt hypothyroidism developed after discharge, an endocrinologist's nexus letter establishing that the in-service subclinical hypothyroidism represented the beginning of the condition that progressed to clinical hypothyroidism post-service may establish the necessary link.
Veterans exposed to ionizing radiation during service — nuclear weapons testing, service near Hiroshima/Nagasaki, reactor operations — may establish service connection through VA's radiation exposure provisions. The thyroid gland is among the most radiation-sensitive organs in the body, and radiation-induced hypothyroidism is a recognized dose-dependent effect. Radiation-exposed veterans should explore 38 CFR 3.311 (radiation risk activities) for the service connection pathway.
For veterans without qualifying Agent Orange service, a private endocrinologist's nexus letter establishing the link between military service and hypothyroidism is essential. An effective nexus letter for hypothyroidism should: (1) confirm current diagnosis with TSH/T4 results and levothyroxine history; (2) review the veteran's service treatment records for any thyroid-related findings; (3) establish that it is "at least as likely as not" that the veteran's thyroid dysfunction began during or was caused by military service conditions; and (4) address any specific in-service risk factors (radiation, chemical exposure, extreme stress, nutritional deficiencies in field conditions).
If you don't qualify for the Agent Orange presumptive, a board-certified physician nexus letter can establish direct service connection. REE Medical offers free consultations to determine if you qualify.
Get My Free Nexus Letter Consultation →Building a strong hypothyroidism claim requires assembling medical evidence that establishes both the diagnosis and the functional severity. The rating level depends almost entirely on documented clinical findings — the more thoroughly your symptoms are documented in medical records, the higher the rating you can support.
The cornerstone of hypothyroidism documentation is thyroid function testing:
Gather all thyroid function labs from VA records (accessible via MyHealtheVet) and private providers. A history of progressively elevated TSH over time demonstrates the chronicity and trajectory of the condition.
A continuous prescription for levothyroxine (Synthroid, Tirosint, or generic levothyroxine sodium) directly satisfies the 10% rating requirement of "requires continuous medication." Request complete pharmacy records from all VA facilities and private pharmacies. The prescription history should show: date started, dose over time (increasing doses may indicate inadequate control), and any periods of medication adjustment. Levothyroxine is almost always a lifelong medication — documentation of this permanence supports the rating.
The difference between a 10% and 30–60% rating is documented symptom burden. Ensure the following are recorded in your medical records if present:
VA will schedule a Compensation and Pension (C&P) exam for hypothyroidism to evaluate the current severity of the condition. The examiner will review your records, examine you, and complete a Disability Benefits Questionnaire (DBQ) for endocrine conditions. The DBQ drives the rating decision.
After the exam, request your DBQ report through MyHealtheVet or through a FOIA request. Review it carefully against what you told the examiner. If symptoms you described are omitted or inaccurately characterized, file a rebuttal as part of a Supplemental Claim or HLR. Particular watch points: (1) ensure all symptoms you reported are listed; (2) check that the examiner noted the presence or absence of cardiovascular findings; (3) verify the rating criteria applied match your actual symptom presentation.
Hypothyroidism causes or contributes to multiple secondary conditions that can be separately rated, often dramatically increasing combined disability ratings. Veterans with a service-connected hypothyroidism rating should systematically evaluate these secondary opportunities.
Thyroid hormone is directly involved in serotonin and dopamine synthesis and receptor sensitivity. Low thyroid hormone produces depression that is often indistinguishable from primary major depressive disorder — the same symptoms, the same treatment resistance, the same functional impairment. Under 38 CFR 3.310, a condition caused or aggravated by a service-connected disability is itself service-connected. Depression secondary to hypothyroidism rates at 10–100% under the mental health diagnostic codes at 38 CFR 4.130, with typical ratings of 30–70% for significant depressive disorders. A private psychiatrist or endocrinologist nexus letter establishing the hypothyroidism-depression link is the key evidence.
Hypothyroidism causes obstructive sleep apnea through two mechanisms: (1) weight gain — hypothyroid-associated weight accumulation increases parapharyngeal fat deposition and airway narrowing; and (2) myxedematous changes in upper airway tissues, reducing airway patency. Both mechanisms are well-documented in endocrinology literature. A sleep medicine physician's nexus letter connecting the veteran's sleep apnea to hypothyroid-related weight gain or tissue changes provides the required nexus. Sleep apnea requiring CPAP rates at 50% (DC 6847), adding $926.53/month over the 10% hypothyroidism base rate — transforming a $175/month benefit into over $1,100/month with this secondary claim alone.
Hypothyroidism causes elevated LDL cholesterol and triglycerides through reduced hepatic LDL receptor expression and impaired cholesterol metabolism. This contributes to accelerated atherosclerosis and increased cardiovascular disease risk. Veterans with service-connected hypothyroidism who develop coronary artery disease, ischemic heart disease, or hypertension may file secondary service connection claims for those conditions through the hypothyroidism-hyperlipidemia-cardiovascular disease pathway. Cardiovascular involvement also supports a higher DC 7903 rating itself (up to 100% with cardiovascular manifestations). Document lipid panel trends correlated with TSH levels for maximum evidentiary impact.
Hypothyroid-related weight gain contributes to orthopedic conditions: knee osteoarthritis, hip degeneration, plantar fasciitis, and lumbar strain. Veterans with secondary musculoskeletal conditions aggravated by hypothyroid-related weight gain may file aggravation claims under 38 CFR 3.310(b). Document the weight gain history and the temporal relationship between hypothyroid onset and worsening of any musculoskeletal conditions.
Hashimoto's thyroiditis — autoimmune hypothyroidism — is the most common cause of hypothyroidism in the U.S. VA does not have a separate diagnostic code for Hashimoto's; it is rated under DC 7903 (hypothyroidism) based on functional impairment, regardless of the underlying autoimmune etiology. The rating criteria are identical: 10% for medication-controlled deficiency, 30% for fatigability/constipation/mental sluggishness, 60% for muscular/weight/mental effects, 100% for severe manifestations.
Hashimoto's disease goes through phases — early hyperthyroid phase, then transition to permanent hypothyroidism — and can cause periods of thyroid storm-like symptoms before the gland "burns out." Veterans who experienced both hyperthyroid and hypothyroid phases may have ratings implications for both conditions depending on when symptoms were documented. Ensure all phases of thyroid disease history are in your medical records and disability file.
Hypothyroidism claims are commonly denied for three reasons: (1) VA found no in-service documentation of thyroid disease; (2) VA found insufficient nexus between military service and hypothyroidism; or (3) VA rated at 10% when the veteran's symptoms support a higher rating. Each denial has specific remedies.
File a Supplemental Claim with a private endocrinologist nexus letter establishing the service connection. The nexus letter should specifically address why the absence of in-service thyroid records is consistent with the timeline of thyroid disease development (hypothyroidism often develops over years with subclinical progression before overt diagnosis). Include a complete medication and lab history showing the earliest available documentation of thyroid dysfunction.
If you believe you have qualifying Agent Orange service that wasn't recognized, file a Supplemental Claim with documentation of your service location — DD-214, ship records, unit records, buddy statements establishing that your vessel or unit operated in a qualifying area. For Blue Water Navy veterans, the VA's ship list is a starting point but not exhaustive — deck logs and ship histories can establish territorial sea operations for unlisted vessels.
File an HLR (Higher-Level Review) if your existing medical records document 30% symptoms (fatigue, cognitive sluggishness, constipation) that the rater failed to account for in the rating decision. File a Supplemental Claim if additional medical records documenting symptoms aren't yet in your file. If your treating physician's records consistently document fatigue or cognitive symptoms related to hypothyroidism and the C&P examiner's DBQ doesn't reflect this, the HLR may correct the oversight. See the VA appeals process overview.
It depends on when you filed. If you filed a hypothyroidism claim before January 2022 that was denied for lack of nexus, you may be eligible to have that claim reconsidered using the new presumptive rule — file a Supplemental Claim referencing the January 2022 regulatory amendment. The effective date for reopened denied claims is generally the date you refile the Supplemental Claim. If you've never filed at all, your effective date will be your new claim filing date. The earlier you file, the earlier your potential effective date and back pay begin accumulating.
No. The requirement for continuous medication is itself the basis for the 10% rating. Under VA regulations, a disability that requires permanent medication is ratable even if the medication controls the condition. Additionally, if you have symptomatic residuals despite medication — fatigue, cognitive problems, weight gain — you qualify for higher ratings based on those symptoms. The fact that levothyroxine is required indefinitely means your hypothyroidism will never be rated at 0% once service-connected.
A normalized TSH on levothyroxine does not eliminate the rating. The rating is based on clinical symptoms and functional impairment — not solely on lab values. Many veterans have a normalized TSH but still experience persistent fatigue, cognitive difficulties, weight challenges, or depression related to their thyroid condition. Document these symptoms consistently in your medical records and report them during C&P exams. A normalized TSH on medication simply means the medication is appropriately dosed — it doesn't mean the condition is resolved or non-ratable.
National Guard and Reserve members who were activated for federal service and served in qualifying locations (Vietnam, Thailand, Korea DMZ) during qualifying periods are eligible for Agent Orange presumptives if they were federally mobilized for that service. Guard and Reserve members on state active duty or inactive duty are generally not eligible for VA benefits unless the condition is connected to federal service periods. Review your service history with a VSO to determine if any periods of federal active duty included qualifying Agent Orange service locations.
Subclinical hypothyroidism (elevated TSH with normal T4 and no overt symptoms) is more difficult to rate than overt hypothyroidism because it typically doesn't require continuous medication and causes fewer functional symptoms. If subclinical hypothyroidism is progressing and your physician has begun levothyroxine therapy, the 10% rating criteria are met. Without medication and without symptoms, a 0% rating (service-connected but non-compensable) may result, which still establishes service connection for future rating increases and secondary condition claims.
Many veterans with hypothyroidism are rated at 10% when they qualify for 30–60% — or are missing secondary condition claims worth hundreds per month. Take our free 2-minute screener.
Take the Free Eligibility Check →